{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:39:51Z","timestamp":1789990791222,"version":"4.0.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T00:00:00Z","timestamp":1471996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T00:00:00Z","timestamp":1471996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS083564"],"award-info":[{"award-number":["NS083564"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG044449"],"award-info":[{"award-number":["AG044449"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s12311-016-0818-5","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T05:57:05Z","timestamp":1472018225000},"page":"595-598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["SPG7 and Impaired Emotional Communication"],"prefix":"10.1007","volume":"16","author":[{"given":"Linwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen N.","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S . H.","family":"Subramony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M.","family":"Heilman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Ashizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,24]]},"reference":[{"key":"818_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00401-013-1115-8","volume":"126","author":"JK Fink","year":"2013","unstructured":"Fink JK. Hereditary spastic paraplegia: clinicopathologic features and emerging molecular mechanisms. Acta Neuropathol. 2013;126:307\u201328.","journal-title":"Acta Neuropathol"},{"key":"818_CR2","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1212\/WNL.0000000000001369","volume":"84","author":"G Pfeffer","year":"2015","unstructured":"Pfeffer G, Pyle A, Griffin H, Miller J, Wilson V, Turnbull L, et al. SPG7 mutations are a common cause of undiagnosed ataxia. Neurology. 2015;84:1174\u20136.","journal-title":"Neurology"},{"key":"818_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/13554794.2012.713496","volume":"20","author":"KM Heilman","year":"2014","unstructured":"Heilman KM, Leon SA, Burtis DB, Ashizawa T, Subramony SH. Affective communication deficits associated with cerebellar degeneration. Neurocase. 2014;20:18\u201326.","journal-title":"Neurocase"},{"key":"818_CR4","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1093\/brain\/aws240","volume":"135","author":"S Klebe","year":"2012","unstructured":"Klebe S, Depienne C, Gerber S, Challe G, Anheim M, Charles P, et al. Spastic paraplegia gene 7 in patients with spasticity and\/or optic neuropathy. Brain. 2012;135:2980\u201393.","journal-title":"Brain"},{"key":"818_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.cell.2005.08.003","volume":"123","author":"M Nolden","year":"2005","unstructured":"Nolden M, Ehses S, Koppen M, Bernacchia A, Rugarli EI, Langer T. The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria. Cell. 2005;123:277\u201389.","journal-title":"Cell"},{"key":"818_CR6","first-page":"617","volume":"31","author":"F Bonn","year":"2010","unstructured":"Bonn F, Pantakani K, Shoukier M, Langer T, Mannan AU. Functional evaluation of paraplegin mutations by a yeast complementation assay. Hum Mutat. 2010;31:617\u201321.","journal-title":"Hum Mutat"},{"key":"818_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2202-11-55","volume":"11","author":"T Sacco","year":"2010","unstructured":"Sacco T, Boda E, Hoxha E, Pizzo R, Cagnoli C, Brusco A, et al. Mouse brain expression patterns of Spg7, Afg3l1, and Afg3l2 transcripts, encoding for the mitochondrial m-AAA protease A. BMC Neurosci. 2010;11:55.","journal-title":"BMC Neurosci"},{"key":"818_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/ng.544","volume":"42","author":"D Di Bella","year":"2010","unstructured":"Di Bella D, Lazzaro F, Brusco A, Plumari M, Battaglia G, Pastore A, et al. Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat Genet. 2010;42:313\u201321.","journal-title":"Nat Genet"},{"key":"818_CR9","doi-asserted-by":"publisher","first-page":"e1002325","DOI":"10.1371\/journal.pgen.1002325","volume":"7","author":"TM Pierson","year":"2011","unstructured":"Pierson TM, Adams D, Bonn F, Martinelli P, Cherukuri PF, Teer JK, et al. Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases. PLoS Genet. 2011;7:e1002325.","journal-title":"PLoS Genet"},{"key":"818_CR10","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1093\/cercor\/bhp135","volume":"19","author":"FM Krienen","year":"2009","unstructured":"Krienen FM, Buckner RL. Segregated fronto-cerebellar circuits revealed by intrinsic functional connectivity. Cereb Cortex. 2009;19:2485\u201397.","journal-title":"Cereb Cortex"},{"key":"818_CR11","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.neuroimage.2012.01.089","volume":"60","author":"O Baumann","year":"2012","unstructured":"Baumann O, Chan E, Mattingley JB. Distinct neural networks underlie encoding of categorical versus coordinate spatial relations during active navigation. NeuroImage. 2012;60:1630\u20137.","journal-title":"NeuroImage"},{"key":"818_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fgene.2015.00311","volume":"6","author":"M Charif","year":"2015","unstructured":"Charif M, Roubertie A, Salime S, Mamouni S, Goizet C, Hamel CP, et al. A novel mutation of AFG3L2 might cause dominant optic atrophy in patients with mild intellectual disability. Front Genet. 2015;6:311.","journal-title":"Front Genet"}],"updated-by":[{"DOI":"10.1007\/s12311-017-0901-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T00:00:00Z","timestamp":1511740800000}}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-016-0818-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12311-016-0818-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-016-0818-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-016-0818-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T16:45:41Z","timestamp":1589733941000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12311-016-0818-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,24]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["818"],"URL":"https:\/\/doi.org\/10.1007\/s12311-016-0818-5","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12311-017-0901-6","asserted-by":"object"}]},"ISSN":["1473-4222","1473-4230"],"issn-type":[{"value":"1473-4222","type":"print"},{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,24]]},"assertion":[{"value":"24 August 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2017","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this article unfortunately contained an incorrect assignment of affiliations of Linwei Zhang and Tetsuo Ashizawa.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Samples were collected under a protocol approved by the University of Florida\u2019s Institutional Review Board (IRB) and following informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Drs. Zhang and McFarland report no disclosures.Dr. Subramony receives research support from IONIS (previously ISIS) Pharmaceuticals, REATA Pharmaceuticals and Horizon Pharmaceuticals.Dr. Heilman receives a grant from NIH #AG044449 and a contract from the Department of Elder Affairs of the State of Florida.Dr. Ashizawa has received grants from IONIS (previously ISIS) Pharmaceuticals, the Myotonic Dystrophy Foundation and the Muscular Dystrophy Association. Dr. Ashizawa receives a grant from NIH (#NS083564) and received an honorarium for serving as a consultant for BioHaven Pharmaceuticals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}